Experience of Pediatric Osteosarcoma of the Extremity at a Single Institution in Taiwan: Prognostic Factors and Impact on Survival

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Stefan Bielack · Journal of Clinical Oncology · 2002 · 1.9K citations

Medicine, Oncology, Surgery +16

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 748 citations · Full text

Medicine, Oncology, Pharmacology +14

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy

Gaetano Bacci, Alessandra Longhi, Michela Versari et al. · Cancer · 2006 · 566 citations

Medicine, Oncology, Surgery +17

Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

Stefano Ferrari, Sigbjørn Smeland, Mario Mercuri et al. · Journal of Clinical Oncology · 2005 · 435 citations

Medicine, Oncology, Surgery +17

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

Alexander J. Chou, Eugenie S. Kleinerman, Mark Krailo et al. · Cancer · 2009 · 239 citations · Full text

Medicine, Oncology, Pharmacology +14